Wall Street’s Key Stock Analysts Research Report, All Buys
#stocks #bullish #buys #analysts #research #WallStreet
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy if you can manage the risk.
These are all Buys if you can manage the risk.
Below are our Buys for Friday, 12 February, as follows:
Altimmune Inc. (NYSE:ALT) was started with a Buy rating and a 36 price target at Guggenheim. The consensus target is higher at 41.40.
Avient Corp. (NASDAQ:AVNT) was raised to Buy from Hold at Stifel, which has a 54 price target. The consensus target is 50.64.
Bed, Bath & Beyond Inc. (NASDAQ:BBBY) was raised at BofA Securities from Hold to Buy with a 38 price target. The consensus target for the retailer is 28.96. BBBY is a heavily shorted stocks that the Reddit players have targeted.
Have a healthy weekend, Keep the Faith!
Palantir Stock (PLTR): BUY Rating, $250 Price Target — The 40% Dislocation
Palantir is down ~40% in 2026 even as Q1 revenue grew 85% and management guided FY2026 to $7.66B. Shayne Heffernan issues a BUY on PLTR with a $250 price target — full breakdown of the business, customers, five-year revenue, every major Wall Street bank target and the corporate outlook.
Boeing and Qatar Airways $BA Update
Elon Musk’s Latest Move Buy $TSLA
Investors should be watching Saudi Arabia
Every story, signed and delivered.
Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.